CWBR - CohBar announces changes to board of directors resignation of CSO

CohBar (NASDAQ:CWBR) has announced changes to its Board of Directors, Scientific Advisory Board, and R&D leadership. CohBar’s founders Drs. Nir Barzilai, Pinchas Cohen, and John Amatruda have transitioned from the company’s Board of Directors to a reconstituted SAB. In addition, Ken Cundy, Ph.D. has resigned from his position as Chief Scientific Officer, effective March 31, 2022. The Co. is pleased to announce the appointment of Kent Grindstaff, Ph.D., as CohBar’s Senior Vice President of Research, effective Jan. 4, 2022. Dr. Grindstaff rejoins the company from BioAge Labs, where he was the Senior Vice President, Discovery Research.

For further details see:

CohBar announces changes to board of directors, resignation of CSO